Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo antiinflammatory activity.
作者:
主题词
投药, 口服(Administration, Oral);氨基吡啶类(Aminopyridines);动物(Animals);消炎药(Anti-Inflammatory Agents);生物利用度(Biological Availability);氨甲酸酯类(Carbamates);结晶学, X线(Crystallography, X-Ray);人类(Humans);Jurkat细胞(Jurkat Cells);淋巴细胞活化(Lymphocyte Activation);淋巴细胞培养试验, 混合(Lymphocyte Culture Test, Mixed);淋巴细胞特异蛋白质酪氨酸激酶p56(Lck)(Lymphocyte Specific Protein Tyrosine Kinase p56(lck));小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);模型, 分子(Models, Molecular);分子结构(Molecular Structure);嘧啶类(Pyrimidines);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);构效关系(Structure-Activity Relationship);T淋巴细胞(T-Lymphocytes)
DOI
10.1021/jm060435i
PMID
16884310
发布时间
2014-11-20
- 浏览86
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文